Potential Use of Cyclodextrins for the Improvement of Ocular Bioavailability of Meloxicam

Journal Title: IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) - Year 2017, Vol 12, Issue 5

Abstract

Meloxicam (MX) is a nonsteroidal anti-inflammatory drug. Also, it is a more distinct COX-2 inhibitor than diclofenac with less secondary effects. Yet, its usage for the treatment of ophthalmic inflammations has retarded due to its low aqueous solubility and dissolution rate. The aim of this study was to prepare the inclusion complexes of MX with cyclodextrins to enhance its aqueous solubility, dissolution rate, and ocular bioavailability. Formulation of those complexes into different ocular delivery systems and also in-vitro and invivo assessments has not been accomplished in the earlier attempts. In this study, MX was complexed with each of hydroxyl propyl-β-cyclodextrin (HP-β-CyD) and β-cyclodextrin (β-CyD) utilizing kneading, co-evaporation, and freeze drying techniques. Moreover, the prepared complexes were discriminated in the solid state by Fourier transform infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC), and powder X-ray diffraction (PXRD). These complexes were incorporated into eye drops, eye gels, and ocuserts using hydroxypropyl methylcellulose (HPMC), sodium carboxy methylcellulose (Sod. CMC), carbopol 940 (CP940), and sodium alginate (Sod. ALG). These formulae were characterized on the subject of drug content, pH, viscosity, in-vitro release characteristics. Kinetic analysis of the release data was done. Real inclusion complexes were obtained with co-evaporation method that confirmed by DSC investigations. The MX release was enhanced by complexation especially with HP-β-CyD. Ocular bioavailability of meloxicam from the selected formulations was investigated. In-vivo study proved that, ocuserts containing MX-HP-CyD complexes showed pronounced ocular bioavailability than MX alone which indicated by higher AUC, Cmax and relative bioavailability values.

Authors and Affiliations

Abd-Elgawad H. Abd-Elgawad, Osama A. Soliman, Marwa S. El-Dahan,, Ghada A. A. El-Emam*

Keywords

Related Articles

Evaluation of Drug Dosing in Renal Failure

Introduction: Rapid accumulation and toxicity can be developed if drugs dosages are not adjusted in patients with chronic kidney diseases (CKD). Objectives: To evaluate the prevalence of correct dosing in chronic kidney...

Poly-𝛽-hydroxybutyrate degradation by Aspergillus fumigates isolated from soil samples collected from Jeddah, Saudi arabia

Poly-β-hydroxybutyrate acid (PHB) is thermoplastic biopolymers, synthesized by some bacterial genera under stress conditions. The degradation of PHB was detected in Petri dish by formation of a clear zone around the fung...

Genetic Variation in Progeny Performance Traits in Soapnut (Sapindus Mukorossi Gaertn.) of Himachal Pradesh.

Evaluation in Progeny performance traits was carried out among different twenty four seed sources and in two D.B.H. classes. Progeny performance traits of soapnut seedlings were recorded at intervals, of 3 months and 6 m...

Study Of Behaviour Of Indian Mongoose Herpestis Javanicus

Mongoose is small feliform carnivores that are native to southern Eurasia and Africa. The genus Suricata Suricata suricata commonly called meercat is found in South Africa. Herpestidae is placed within the suborder Felif...

Comparative Study of Yeast Growth Kinetics in Different Reactors

This study aims at investigating three different reactors (air-lift fermenter, bubble column reactor, continuous stirred-tank reactor) to evaluate their performance with respect to baker’s yeast (Active Dry Yeast powder)...

Download PDF file
  • EP ID EP390925
  • DOI 10.9790/3008-1205017996
  • Views 110
  • Downloads 0

How To Cite

Abd-Elgawad H. Abd-Elgawad, Osama A. Soliman, Marwa S. El-Dahan, , Ghada A. A. El-Emam* (2017). Potential Use of Cyclodextrins for the Improvement of Ocular Bioavailability of Meloxicam. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS), 12(5), 79-96. https://europub.co.uk/articles/-A-390925